We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

Dopamine Genetics 01

This study will be conducted throughout Germany in four study centers.

Background of the study

Two thirds of the population are currently overweight. Excess weight causes a number of illnesses, such as diabetes and heart attack as well as joint problems.

The causes of overweight are:

  • a high-calorie and high-fat diet
  • too little exercise

In addition, the brain has a decisive influence on eating behavior and thus also on body weight. In particular, the reward system (dopaminergic system) plays a key role here. Dopamine is a neurotransmitter that can trigger a reward sensation after eating. Overweight people have a reduced reward sensation after eating. This is probably due to a decreased release of dopamine in the brain.

Our genes also influence our body weight. An important risk gene influences the reward system in the brain.

The planned study will investigate whether this gene alters the effect of dopamine in the brain. 

 

Suitable participants  

  • women and men between the ages of 18 and 70
  • who have a BMI > 30 kg/m2
  • and do not have any metal parts in the body.

 

Study procedure

The study investigates the effect of an approved drug on weight loss. The drug is to be taken for 18 weeks; half of the participants will take the approved drug, the other half a placebo (tablet without active ingredient).

 We examine the influence of the drug on

  • body fat,
  • various metabolic processes and
  • the insulin action in the brain depending on the genetic background.

 

Examinations

  • physical examination
  • blood collection and urine analysis
  • glucose tolerance test
  • MRI

 

Compensation for expenses

You will receive appropriate financial compensation for the expenses incurred. This study has been approved by the Ethics Committee.

 

Participating Clinics

Tübingen
Prof. Martin Heni
Universitätsklinikum Tübingen
Tel.: 07071–2980 687
stoffwechsel(at)med.uni-tuebingen.de

 

Lübeck
Prof. Sebastian Schmid
Uniklinikum Schleswig-Holstein
Tel.: 0451–3101 2830
susanne.behling(at)uksh.de

 

Cologne
Dr. Michael Faust
Universitätsklinikum Köln
Tel.: 0221–478–32 896
endokrinologie(at)uk-koeln.de

 

Munich
Prof. Jochen Seißler, Dr. Andreas Lechner
Ludwig-Maximilians-Universität
Tel.: 089–4400–52234
studienzentrum-diabetes(at)med.uni-muenchen.de